Dexcel Pharma Technologies Ltd.

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 40% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
5 60% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dexcel Pharma Technologies Ltd.'s trades of Roivant Sciences Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
408.73
Quantity 31,653 +2.6%
Value US$1,180,085
Transaction date
Purchase
Price
127.02
Quantity 7,604 -30.3%
Value US$1,650,319
Transaction date
Purchase
Price
353.20
Quantity 35,981 +10.1%
Value US$4,771,587
Transaction date
Sale
Price
0.29
Quantity 110,000 -2.5%
Value US$31,900
Transaction date
Sale
Price
0.32
Quantity 80,000 -1.8%
Value US$25,440
Transaction date
Sale
Price
0.31
Quantity 725,951 -14.1%
Value US$224,319
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-14 2022-11-10
B Purchase
31,653 +2.6%
408.73
US$1,180,085 		31,653 +2.6% 408.73 US$1,180,085
2022-04-26 2022-04-25
B Purchase
7,604 -30.3%
127.02
US$1,650,319 		7,604 -30.3% 127.02 US$1,650,319
2022-04-26 2022-04-22
B Purchase
35,981 +10.1%
353.20
US$4,771,587 		35,981 +10.1% 353.20 US$4,771,587
2021-06-03 2021-06-03
S Sale
857,506 -19.1%
2.25
US$1,932,304 		857,506 -19.1% 2.25 US$1,932,304
2021-06-03 2021-06-02
S Sale
61,211 -1.3%
2.56
US$156,553 		61,211 -1.3% 2.56 US$156,553
2020-02-04 2020-02-04
S Sale
110,000 -2.5%
0.29
US$31,900 		110,000 -2.5% 0.29 US$31,900
2020-02-04 2020-02-03
S Sale
80,000 -1.8%
0.32
US$25,440 		80,000 -1.8% 0.32 US$25,440
2020-02-04 2020-01-31
S Sale
725,951 -14.1%
0.31
US$224,319 		725,951 -14.1% 0.31 US$224,319